138 related articles for article (PubMed ID: 29660420)
1. Tracking tumor kinetics in patients with germline CYLD mutations.
Brown S; Worthy SA; Langtry JAA; Rajan N
J Am Acad Dermatol; 2018 Nov; 79(5):949-951. PubMed ID: 29660420
[No Abstract] [Full Text] [Related]
2. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.
Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N
J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270
[TBL] [Abstract][Full Text] [Related]
3. Inherited cylindromas: lessons from a rare tumour.
Rajan N; Ashworth A
Lancet Oncol; 2015 Sep; 16(9):e460-e469. PubMed ID: 26370355
[TBL] [Abstract][Full Text] [Related]
4. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
5. Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
Danilenko M; Stamp E; Stocken DD; Husain A; Zangarini M; Cranston A; Stones R; Sinclair N; Hodgson K; Bowett SA; Roblin D; Traversa S; Plummer R; Veal G; Langtry JAA; Ashworth A; Burn J; Rajan N
JAMA Dermatol; 2018 Aug; 154(8):913-921. PubMed ID: 29955768
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.
Bülau JE; Kreipe HH; Jessen E; von Hardenberg S; Auber B; Grohé C; Leo F
Clin Lung Cancer; 2021 Nov; 22(6):e795-e798. PubMed ID: 33896728
[No Abstract] [Full Text] [Related]
7. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.
Rajan N; Langtry JA; Ashworth A; Roberts C; Chapman P; Burn J; Trainer AH
Arch Dermatol; 2009 Nov; 145(11):1277-84. PubMed ID: 19917957
[TBL] [Abstract][Full Text] [Related]
8. Blaschkoid distribution of cylindromas in a germline CYLD mutation carrier.
Furuichi M; Makino T; Yamakoshi T; Matsui K; Shimizu T
Br J Dermatol; 2012 Jun; 166(6):1376-8. PubMed ID: 22296260
[No Abstract] [Full Text] [Related]
9. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas.
Nasti S; Pastorino L; Bruno W; Gargiulo S; Battistuzzi L; Zavattaro E; Leigheb G; De Francesco V; Tulli A; Mari F; Scarrà GB; Ghiorzo P
Clin Genet; 2009 Nov; 76(5):481-5. PubMed ID: 19807742
[No Abstract] [Full Text] [Related]
10. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.
Nagy N; Rajan N; Farkas K; Kinyó A; Kemény L; Széll M
Acta Derm Venereol; 2013 Nov; 93(6):743-5. PubMed ID: 23584127
[No Abstract] [Full Text] [Related]
11. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
[TBL] [Abstract][Full Text] [Related]
12. Milia: a useful clinical marker of CYLD mutation carrier status.
Bajwa DS; Nasr B; Carmichael AJ; Rajan N
Clin Exp Dermatol; 2018 Mar; 43(2):193-195. PubMed ID: 29023940
[No Abstract] [Full Text] [Related]
13. Inherited pulmonary cylindromas: extending the phenotype of CYLD mutation carriers.
Brown SM; Arefi M; Stones R; Loo PS; Barnard S; Bloxham C; Stefanos N; Langtry JAA; Worthy S; Calonje E; Husain A; Rajan N
Br J Dermatol; 2018 Sep; 179(3):662-668. PubMed ID: 29569226
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous adenoid cystic carcinoma with lung and lymph node metastases.
Doganay L; Bilgi S; Aygit C; Altaner S
J Eur Acad Dermatol Venereol; 2004 May; 18(3):383-5. PubMed ID: 15096169
[No Abstract] [Full Text] [Related]
15. CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma.
Williams EA; Montesion M; Sharaf R; Corines J; Patel PJ; Gillespie BJ; Pavlick DC; Sokol ES; Alexander BM; Williams KJ; Elvin JA; Ross JS; Ramkissoon SH; Hemmerich AC; Tse JY; Mochel MC
Mod Pathol; 2020 Dec; 33(12):2614-2625. PubMed ID: 32461623
[TBL] [Abstract][Full Text] [Related]
16. Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.
Cranston A; Stocken DD; Stamp E; Roblin D; Hamlin J; Langtry J; Plummer R; Ashworth A; Burn J; Rajan N
Trials; 2017 Mar; 18(1):111. PubMed ID: 28270164
[TBL] [Abstract][Full Text] [Related]
17. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Adenoid Cystic Carcinoma with Perineural Invasion Diagnosed in the Foot: A Case Report.
Agunbiade M; Lalehparvar S; Khaladj M
J Am Podiatr Med Assoc; 2017 Sep; 107(5):457-460. PubMed ID: 28530493
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant multiple cylindromas associated with solitary lung cylindroma.
Vernon HJ; Olsen EA; Vollmer RT
J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):397-400. PubMed ID: 2842382
[TBL] [Abstract][Full Text] [Related]
20. Multiple cylindromas. The 'turban tumor'.
Nerad JA; Folberg R
Arch Ophthalmol; 1987 Aug; 105(8):1137. PubMed ID: 2820364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
